Bleichroeder LP’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Bleichroeder LP’s Portfolio RVMDW Stock Details RVMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$358K	Hold	200,000	–	–	0.06%	53
2025 Q4	$188K	Hold	200,000	–	–	0.03%	56
2025 Q3	$60K	Hold	200,000	–	–	0.01%	63
2025 Q2	$52.5K	Hold	200,000	–	–	0.01%	64
2025 Q1	$7.6K	Hold	200,000	–	–	﹤0.01%	75
2024 Q4	$36K	Hold	200,000	–	–	0.01%	66
2024 Q3	$28K	Hold	200,000	–	–	0.01%	64
2024 Q2	$20.4K	Hold	200,000	–	–	0.01%	67
2024 Q1	$36.5K	Hold	200,000	–	–	0.01%	64
2023 Q4	$66K	Buy	+200,000	New	+$89.3K	0.01%	57

Other funds holding RVMDW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return